Douglas Jennings, PharmD, FCCP, FAHA
Douglas Jennings, PharmD, FCCP, FAHA
Douglas Jennings, PharmD, FCCP, FAHA, FACC, currently practices as the clinical pharmacy manager in heart transplant and mechanical circulatory support at New York Presbyterian Columbia University Medical Center. He is a past chair of the American College of Clinical Pharmacy (ACCP) Cardiology PRN, and he is a fellow of ACCP, the American Heart Association, and the American College of Cardiology.
Articles
Aug 10, 2017 @05:22 AM
This article discusses the potential role of tirofiban as a complementary agent to the newer oral P2Y12 receptor blockers in STEMI patients.

Dec 2, 2016 @06:35 AM
A recently-published study explores the outcomes associated with the combination of DOACs and dual anti platelet therapy.

Sep 28, 2016 @08:30 AM
This article summarizes recent literature surrounding the use of tolvaptan for acute heart failure.

Aug 31, 2016 @03:18 AM
Many exciting clinical trial results are being presented at ESC Congress 2016 and published simultaneously this week.

Aug 26, 2016 @07:30 AM
PAD patients have consistently been undertreated with antiplatelets, despite an overwhelming majority having pre-existing cardiovascular disease.

Aug 19, 2016 @02:48 AM
Although fixed daily doses of NOACs have demonstrated favorable efficacy and safety compared with warfarin, the impact of worsening renal function on these medications over time hasn't been evaluated.

Aug 15, 2016 @03:37 AM
Clinical trial data don't always reflect real-world experience.

Aug 9, 2016 @02:54 AM
Sepsis leads to approximately 1 million hospitalizations in the United States yearly, and atrial fibrillation is the most common arrhythmia to complicate its course.

Aug 3, 2016 @01:52 AM
This article highlights the latest literature surrounding both new and old heart failure therapies.

Jul 8, 2016 @12:38 PM
Depression affects 10% to 40% of patients with heart failure, depending on disease severity.

Jun 30, 2016 @02:30 AM
Community pharmacists are certainly accustomed to telling patients to use less expensive generic alternatives when they're available, but how many are advising patients to pay with cash instead of using prescription drug insurance?

Jun 22, 2016 @01:59 AM
This article summarizes recent literature evaluting the risks and benfits of resuming anticoaguation in atrial fibrillation patients who experience gastrointestinal bleeding.

Jun 16, 2016 @02:49 AM
This article focus on the management of lipid therapy and the use of statins in patients with chronic kidney disease and those on hemodialysis

Jun 6, 2016 @03:44 AM
This article explores recent evidence describing the potential benefits of vitamin D supplementation in patients with heart failure and reduced ejection fraction.

Jun 1, 2016 @01:32 AM
A recent network meta-analysis compared the various P2Y12 receptor antagonists availabe for treating patients with STEMI who undergo primary PCI

May 23, 2016 @01:10 AM
This article highlights the latest evidence from both the AHA/ACC and ESC guidelines, which were both published this past weekend.

May 18, 2016 @08:45 AM
Despite advances in preventative drug therapy, cardiovascular disease remains the leading cause of death in the United States.

May 10, 2016 @07:42 AM
All pharmacists know that loperamide is an OTC antidiarrheal, but they may not be familiar with its mu-opioid agonist activity.

May 9, 2016 @05:53 AM
The US Preventive Services Task Force has critically evaluated the literature and provided recommendations regarding aspirin use for primary prevention of CVD and CRC.

Apr 11, 2016 @08:11 AM
A community pharmacist intervention program reduced the estimated risk for cardiovascular events by 21% in 3 months.

Apr 6, 2016 @01:21 AM
Certain subspecialties within the pharmacy profession may be well suited for a postgraduate year 3 residency program.

Mar 30, 2016 @10:27 AM
How long should dual antiplatelet therapy be continued for patients with ischemic heart disease?

Mar 29, 2016 @04:50 AM
Here are 7 clinical pearls for pharmacists to remember when selecting anticoagulants for patients with non-valvular atrial fibrillation.

Mar 22, 2016 @03:59 AM
A recent ProPublica analysis found that physicians who receive payments from drug companies may exhibit different prescribing patterns with respect to brand-name medications.

Mar 15, 2016 @09:11 AM
The emergence of new oral anticoagulants presents pharmacists with an opportunity to intervene in assisting patients with selecting the most appropriate drug therapy.

Mar 8, 2016 @09:22 AM
Many patients wouldn't question the use of doctor" when addressing physicians, dentists, or even optometrists, but the title likely seems foreign when addressing pharmacists, physical therapists, and nurse practitioners.

Feb 17, 2016 @09:36 AM
This article highlights key pearls for optimizing antiplatelet therapy for prevention of secondary stroke.

Feb 10, 2016 @03:08 AM
Left ventricular assist devices have emerged as a lifesaving treatment option for those with advanced heart failure.